Increased Conformational Flexibility of HLA-B∗27 Subtypes Associated with Ankylosing Spondylitis

Arthritis and Rheumatology

Volumn 68, Issue 5, 2016, Pages 1172-1182

  Loll, Bernhard ^a   Fabian, Heinz ^f   Huser, Hans ^b   Hee, Chee Seng ^c   Ziegler, Alexander ^d   Uchanska Ziegler, Barbara ^b   Ziegler, Andreas ^e  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF BONN   (Germany)

^e Ziegler Biosolutions   (Germany)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; HLA-B*27:04 ANTIGEN; HLA-B*27:06 ANTIGEN; PROTEIN BINDING; VIPR1 PROTEIN, HUMAN;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; HUMAN; INFRARED SPECTROSCOPY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY; CHEMISTRY; CONFORMATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR DOCKING;

CRYSTALLOGRAPHY, X-RAY; HLA-B27 ANTIGEN; HUMANS; MOLECULAR CONFORMATION; MOLECULAR DOCKING SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84964689657     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39567     Document Type: Article

References (52)

1. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al., Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889-99.
2. Khan MA, Ball EJ., Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002; 16: 675-90.
3. Lopez de Castro JA., HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007; 108: 27-33.
4. Uchanska-Ziegler B, Loll B, Fabian H, Hee CS, Saenger W, Ziegler A., HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system. Eur J Cell Biol 2012; 91: 274-86.
5. Sorrentino R, Bockmann RA, Fiorillo MT., HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity. Mol Immunol 2014; 57: 22-7.
6. Bowness P., HLA-B27. Annu Rev Immunol 2015; 33: 29-48.
7. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC., Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506-12.
8. Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD., Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis 2012; 71: 589-95.
9. Abualrous ET, Fritzsche S, Hein Z, Al-Balushi MS, Reinink P, Boyle LH, et al., F pocket flexibility influences the tapasin dependence of two differentially disease-associated MHC class I proteins. Eur J Imunol 2015; 45: 1248-57.
10. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al., Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nature Commun 2015; 6: 7146.
11. Sanz-Bravo A, Campos J, Mazariegos MS, Lopez de Castro JA., Dominant role of the ERAP1 polymorphism R528K in shaping the HLA-B27 peptidome through differential processing determined by multiple peptide residues. Arthritis Rheumatol 2015; 67: 692-701.
12. Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, et al., Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004; 199: 271-81.
13. Fabian H, Huser H, Narzi D, Misselwitz R, Loll B, Ziegler A, et al., HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 2008; 376: 798-810.
14. Fabian H, Huser H, Loll B, Ziegler A, Naumann D, Uchanska-Ziegler B., HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Arthritis Rheum 2010; 62: 978-87.
15. Fabian H, Loll B, Huser H, Naumann D, Uchanska-Ziegler B, Ziegler A., Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. FEBS J 2011; 278: 1713-27.
16. Loll B, Zawacka A, Biesiadka J, Petter C, Rueckert C, Saenger W, et al., Preliminary x-ray diffraction analysis of crystals from the recombinantly expressed human major histocompatibility antigen HLA-B∗2704 in complex with a viral peptide and with a self-peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005; 61: 939-41.
17. Zawacka A, Loll B, Biesiadka J, Saenger W, Uchanska-Ziegler B, Ziegler A., X-ray diffraction analysis of crystals from the human major histocompatibility antigen HLA-B∗2706 in complex with a viral peptide and with a self-peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005; 61: 1097-9.
18. Emsley P, Lohkamp B, Scott WG, Cowtan K., Features and development of Coot. Acta Crystallogr D Biol Crystallogr 2010; 66: 486-501.
19. Murshudov GN, Vagin AA, Dodson EJ., Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53: 240-55.
20. Perrakis A, Morris R, Lamzin VS., Automated protein model building combined with iterative structure refinement. Nat Struct Biol 1999; 6: 458-63.
21. Winn MD, Isupov MN, Murshudov GN., Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 2001; 57: 122-33.
22. Laskowski RA, McArthur MW, Moss DS, Thornton JM., PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26: 283-91.
23. Chen VB, Arendall WB III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, et al., MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66: 12-21.
24. DeLano WL., The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific; 2002.
25. Fabian H, Mantele W., Infrared spectroscopy of proteins. In:, Chalmers JM, Griffiths PR, editors. Handbook of vibrational spectroscopy. Chichester (England): J Wiley; 2002. p. 3399-425.
26. Kumar P, Ziegler A, Grahn A, Hee CS, Ziegler A., Leaving the structural ivory tower, assisted by interactive 3D PDF. Trends Biochem Sci 2010; 35: 419-22.
27. Madden DR., The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995; 13: 587-622.
28. Ruckert C, Fiorillo MT, Loll B, Moretti R, Biesiadka J, Saenger W, et al., Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem 2006; 281: 2306-16.
29. Barth A., Infrared spectroscopy of proteins. Biochim Biophys Acta 2007; 1767: 1073-101.
30. Englander SW, Kallenbach NR., Hydrogen exchange and structural dynamics of proteins and nucleic acids. Q Rev Biophys 1983; 16: 521-655.
31. Ziegler A, Loll B, Misselwitz R, Uchanska-Ziegler B., Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. Adv Exp Med Biol 2009; 649: 177-95.
32. Fiorillo MT, Ruckert C, Hulsmeyer M, Sorrentino R, Saenger W, Ziegler A, et al., Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005; 280: 2962-71.
33. Benjamin R, Parham P., Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137-42.
34. Lopez de Castro JA., HLA-B27-bound peptide repertoires: their nature, origin and pathogenetic relevance. Adv Exp Med Biol 2009; 649: 196-209.
35. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saenger W, et al., HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem 2002; 277: 47844-53.
36. Winkler K, Winter A, Ruckert C, Uchanska-Ziegler B, Alexiev U., Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 2007; 93: 2743-55.
37. Ziegler A, Muller CA, Bockmann RA, Uchanska-Ziegler B., Low-affinity peptides and T-cell selection. Trends Immunol 2009; 30: 53-60.
38. Ramos M, Paradela A, Vazquez M, Marina A, Vazquez J, Lopez de Castro JA., Differential association of HLA-B∗2705 and B∗2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 2002; 277: 28749-56.
39. Schittenhelm RB, Lim Kam Sian TC, Wilmann PG, Dudek NL, Purcell AW., Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol 2015; 67: 702-13.
40. Narzi D, Becker CM, Fiorillo MT, Uchanska-Ziegler B, Ziegler A, Bockmann R., Dynamical characterization of two differentially disease associated MHC class I proteins in complex with viral and self-peptides. J Mol Biol 2012; 415: 429-42.
41. Liu Y, Jiang L, Cai Q, Danoy P, Barnardo MC, Brown MA, et al., Predominant association of HLA-B∗2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens 2010; 75: 61-4.
42. Mou Y, Wu Z, Gu J, Liao Z, Lin Z, Wei Q, et al., HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China. Tissue Antigens 2010; 75: 56-60.
43. Lopez de Castro JA., HLA-B27 and ankylosing spondylitis: tales from China. Tissue Antigens 2010; 75: 9-11.
44. Narzi D, Winkler K, Saidowsky J, Misselwitz R, Ziegler A, Bockmann RA, et al., Molecular determinants of major histocompatibility complex class I complex stability: shaping antigenic features through short and long range electrostatic interactions. J Biol Chem 2008; 283: 23093-103.
45. Cauli A, Shaw J, Giles J, Hatano H, Rysnik O, Payeli S, et al., The arthritis-associated HLA-B∗27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B∗27:09. Rheumatology (Oxford) 2013; 52: 1952-62.
46. Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G,. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev 2010; 233: 181-202.
47. 2m-deposition disease? Trends Immunol 2003; 24: 73-6.
48. Nurzia E, Narzi D, Cauli A, Mathieu A, Tedeschi V, Caristi S, et al., Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. PLoS One 7: e32865.
49. Reboul CF, Meyer GR, Porebski BT, Borg NA, Buckle AM., Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex. PLoS Comput Biol 2012; 8: e1002404.
50. Beerbaum M, Ballaschk M, Erdmann N, Schnick C, Diehl A, Uchanska-Ziegler B, et al., NMR spectroscopy reveals unexpected structural variation at the protein-protein interface in MHC class I molecules. J Biomol NMR 2013; 57: 167-78.
51. 2-microglobulin and the evolution of interfaces in MHC class I molecules. Immunogenetics 2013; 65: 157-72.
52. Ballaschk M, Ziegler A, Uchanska-Ziegler B, Schmieder P., Dynamics of HLA-B27 molecules are highly dependent on subtype and peptide ligand [poster]. In: Sklenar V, editor. EUROMAR 2015 programme and abstract book. European Magnetic Resonance Scientific Congress; 2015 July 5-10; Prague, Czech Republic. Brno (Czech Republic): Masaryk University Press. p. 524-5.